COL-6 International Consortium for Collagen VI Research

Fundación Noelia reaffirms its commitment to promoting and supporting scientific research aimed at understanding, treating, and ultimately curing Collagen VI Related Congenital Muscular Dystrophy (COL6-CMD). In this context, participation in international initiatives is essential to accelerate progress in the field.

The “COL-6 International Consortium for Collagen VI Research” has been established with the objective of advancing scientific knowledge and developing therapeutic strategies for COL6-CMD through international cooperation and data sharing. This initiative brings together institutions and experts to coordinate efforts and maximize the impact of research.

The Consortium’s proposal outlines several key strategic objectives. First, the identification of gene-directed therapies, including gene therapy, gene editing, and RNA-based approaches, aimed at correcting or mitigating the pathological features caused by COL6-CMD variants. In addition, the development of animal models that accurately replicate the clinical and pathological characteristics of the disease will support therapeutic testing.

Another essential focus is preclinical validation, which involves assessing the safety and efficacy of candidate therapies before they are introduced into human studies. The Consortium will also work on identifying optimal delivery systems to ensure targeted and effective distribution of treatments.

Clinical trial readiness is another priority, with efforts directed toward developing outcome measures and biomarkers that facilitate a smooth transition into clinical phases. At the same time, patient-centered research will be promoted by actively involving patient communities in defining research priorities and directions.

Finally, the Consortium places strong emphasis on collaboration and responsible data sharing, fostering open communication and international cooperation among participating institutions.

Participation in this Consortium is fully aligned with the mission and strategic goals of Fundación Noelia and is expected to make a significant contribution to advancing research for the benefit of individuals affected by COL6-CMD.

Other participants in the COL-6 International Consortium for Collagen VI Research, in addition to Fundación Noelia, include the National Institutes of Health (NIH), Institut de Recerca Sant Joan de Déu, University College London, the Research Center in Myology, Instituto de Investigación Sanitaria Biobizkaia and Biogipuzkoa, and Cure CMD.

Proyect: https://fundacionnoelia.org/en/research-projects/international-consortium-for-col6-cmd-research/